Presentation EuroPCR 2024 Hybrid coronary revascularisation–10-year clinical outcomes of the prospective randomised study. Presenter: Mateusz Tajstra May 15, 2024 REGISTER for free or LOG IN to view this content Coronary Cardiac Surgery Presentation EuroPCR 2024 Up Next Presentation EuroPCR 2024 First report of an IDE pivotal study of a dedicated splitting device during TAVR Presenter: Danny Dvir May 15, 2024 More slides + Presentation EuroPCR 2024 One-month DAPT followed by 5-month Ti - cagrelor monotherapy in acute coronary syndromes with DCB - results from REC-CAGEFREE II Presenter: Ling Tao May 15, 2024 Presentation EuroPCR 2024 Is coronary artery bypass surgery cost-effective compared with contemporary PCI? A FAME 3 analysis Presenter: Frederik Zimmermann May 15, 2024 We Recommend
Presentation EuroPCR 2024 First report of an IDE pivotal study of a dedicated splitting device during TAVR Presenter: Danny Dvir May 15, 2024
Presentation EuroPCR 2024 One-month DAPT followed by 5-month Ti - cagrelor monotherapy in acute coronary syndromes with DCB - results from REC-CAGEFREE II Presenter: Ling Tao May 15, 2024
Presentation EuroPCR 2024 Is coronary artery bypass surgery cost-effective compared with contemporary PCI? A FAME 3 analysis Presenter: Frederik Zimmermann May 15, 2024